- UroToday Home
- Beyond the Abstracts
- Urologic Oncology
Prostate Cancer
Molecular Genetics of Prostate Cancer and Role of Genomic Testing - Beyond the Abstract
January 6, 2023
How Well Do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis - Beyond the Abstract
January 4, 2023
The Cell-Free DNA Methylome Captures Distinctions Between Localized and Metastatic Prostate Tumors - Beyond the Abstract
December 12, 2022
The Current Role of Precision Surgery in Oligometastatic Prostate Cancer - Beyond the Abstract
December 8, 2022
Surgical Planning for iT3 Prostate Cancer: How to Estimate Whether Preoperative MRI is Misleading You - Beyond the Abstract
December 7, 2022
Optical Genome Mapping Identifies Clinically Relevant Genomic Rearrangements in Prostate Cancer Biopsy Sample - Beyond the Abstract
November 2, 2022
Prostate Cancer in Australia: The Paradox of Falling Localized Disease Rates yet Continued Mortality Reduction - Beyond the Abstract
October 19, 2022
Post-Diagnostic Health Behaviour Scores in Relation to Fatal Prostate Cancer - Beyond the Abstract
October 13, 2022
Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer - Beyond the Abstract
October 13, 2022
Association of Prostate Volume and the Incidence of Prostate Cancer Determined on MRI-Fusion Biopsy: A systemic Review - Beyond the Abstract
October 6, 2022